Patent and trademark applicants may ask for reinstatement if failing to comply within a statutory time period due to the heated COVID-19 outbreak
As the title of this article suggests, if the delay of a statutory time period is caused by natural calamity or other causes not attributable to the applicant, according to Article 17 of the Patent Act and Article 12 of the Enforcement Rules of the Patent Act, or Article 8 of the Trademark Act and Article 9 of the Enforcement Rules of the Trademark Act, the applicant may file a request for reinstatement.
TIPO Publishes the draft amendments to the Copyright Act on January 30, 2020
To make Taiwan’s copyright laws more comprehensive, TIPO decided to propose draft amendments to the Copyright Act in terms of the major issues that can affect the public deeply. In total, 32 articles were amended, 5 articles were added, and three articles were deleted. The points to the amendments are as follows:
Joseph Straus: "China's Efforts in IP Protection Can Stand Scrutiny"
"Since the entering into force of the ever first Chinese patent act in 1985, China has continuously developed and improved its IP protection. Its efforts in this regard can stand scrutiny even in comparison with developments in Japan and Republic of Korea," said Joseph Straus, Professor of Law at the University of Munich, recognizing China's IP achievements made in the past 40 years in an interview with China Intellectual Property News recently.
China's IP Protection Development Is Widely Acknowledged
In recent years, China's IP protection work has made remarkable achievements and is widely acknowledged by the IP community, thanks to constant improvement of relevant laws, regulations and policy system, enhancement of law enforcement, profound reform in the field of judicial trial，among other advancement.
Approval for Drugs Sped Up to Fight Virus
Medicines, protective equipment and testing kits produced in large numbers
China has simplified the process for approving drugs and protective gear necessary to tackle the novel coronavirus pneumonia epidemic, allowing medical professionals and patients greater access to safe and effective products, officials said on Tuesday.
